Understanding the molecular mechanisms played by B cells and the cytokine IL-11 and IL-17A in progressive erosive disease can help in designing novel treatment approaches aimed at halting joint damage and disability in RA. The gene discussed is IL11; the disease is rheumatoid arthritis.